人类可卡因使用障碍的分子遗传学
本综述聚焦人类可卡因使用障碍(CUD)的分子遗传学,梳理了候选基因关联研究与全基因组关联研究(GWAS)发现的遗传风险因素,并讨论了CUD与其他精神障碍的共享遗传因素、可卡因诱导的基因表达与表观遗传改变,以及仍处于早期阶段的药物遗传学。
要点
- CUD遗传力高,遗传风险因素经候选基因关联研究与GWAS研究。
- CUD与精神分裂症、攻击行为、反社会或冒险行为等存在共享遗传因素。
- 可卡因急慢性使用诱导基因表达与表观遗传改变,参与神经元适应和脑回路重塑。
核心结论
- CUD是遗传与环境共同驱动的复杂多因素障碍,个体基因组编码的生物学因素至少部分解释使用可卡因者是否发展为CUD的差异。
- 深入理解CUD的遗传基础有助于寻找有效治疗并推动个性化医疗。
研究设计与样本
- 本文为综述,汇总CUD的候选基因关联研究(CGAS)与全基因组关联研究(GWAS)以及转录组学研究。
- 转录组学研究在人类神经元细胞和死后脑组织中进行。
主要发现
- CUD的遗传力估计值高。
- CUD与精神分裂症、攻击行为、反社会或冒险行为等多种精神障碍存在高共病,且这些共病与更差的一生轨迹相关。
- 可卡因使用和慢性滥用诱导基因表达改变与表观遗传修饰。
- 部分基因的表达受可卡因改变,同时携带该障碍的遗传风险变异。
临床怎么用
- 从遗传与表观遗传角度理解CUD的个体易感性差异,关注与CUD共病的其他精神障碍的共享遗传因素。
- CUD治疗药物遗传学仍处早期阶段,临床决策需结合遗传研究进展谨慎推进。
局限性
- 原文未系统报告综述的检索范围与纳入排除标准。
- CUD治疗药物遗传学仍处于早期阶段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug addiction, one of the major health problems worldwide, is characterized by the loss of control in drug intake, craving, and withdrawal. At the individual level, drugs of abuse produce serious consequences on health and have a negative impact on the family environment and on interpersonal and work relationships. At a wider scale, they have significant socio-economic and public health consequences and they cause delinquency and citizen insecurity. Cocaine, a psychostimulant substance, is one of the most used illicit drugs, especially in America, Western Europe, and Australia. Cocaine use disorders (CUD) are complex multifactorial conditions driven by both genetic and environmental influences. Importantly, not all people who use cocaine develop CUD, and this is due, at least in part, to biological factors that are encoded in the genome of individuals. Acute and repeated use of cocaine induces epigenetic and gene expression changes responsible for the neuronal adaptations and the remodeling of brain circuits that lead to the transition from use to abuse or dependence. The purpose of this review is to delineate such factors, which should eventually help to understand the inter-individual variability in the susceptibility to cocaine addiction. Heritability estimates for CUD are high and genetic risk factors for cocaine addiction have been investigated by candidate gene association studies (CGAS) and genome-wide association studies (GWAS), reviewed here. Also, the high comorbidity that exists between CUD and several other psychiatric disorders is well known and includes phenotypes like schizophrenia, aggression, antisocial or risk-taking behaviors. Such comorbidities are associated with a worse lifetime trajectory, and here we report shared genetic factors that may contribute to them. Gene expression changes and epigenetic modifications induced by cocaine use and chronic abuse in humans are addressed by reviewing transcriptomic studies performed on neuronal cells and on postmortem brains. We report some genes which expression is altered by cocaine that also bear genetic risk variants for the disorder. Finally, we have a glance to the pharmacogenetics of CUD treatments, still in early stages. A better understanding of the genetic underpinnings of CUD will foster the search of effective treatments and help to move forward to personalized medicine.
引用
- Fernàndez-Castillo N, Cabana-Domínguez J, Corominas R, et al. Molecular genetics of cocaine use disorders in humans. Mol Psychiatry. 2021. PMID: 34453125. doi:10.1038/s41380-021-01256-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。